Company Market News

Centessa Pharmaceuticals plc (NASDAQ: CNTA)
8:00 PM UTC, 06/20/25
Last: $12.43 Change: -0.25 %Change: -1.97% Volume: 1,612,616
Morgan Stanley Lifts Price Target on Centessa Pharmaceuticals to $27 From $26, Keeps Overweight Rating

Back

Last updated: 11/13/2024 6:43:59 AM

06:43 AM EST, 11/13/2024 (MT Newswires) -- Centessa Pharmaceuticals' (CNTA) US stock has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $22 to $35.

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

http://www.mtnewswires.com
Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.




Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.